VEGFA and hepatocellular carcinoma: This study has established and validated a nomogram by incorporating pretreatment CEUS quantitative parameters and baseline clinical characteristics to predict the anti-PD-1 plus anti-VEGF treatment efficacy in advanced HCC patients, which may help in clinical decision-making for patients with advanced HCC.